Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine

Clozapine, a dibenzodiazepine developed in 1961, is a multireceptorial atypical antipsychotic approved for the treatment of resistant schizophrenia. Since its introduction, it has remained the drug of choice in treatment-resistant schizophrenia, despite a wide range of adverse effects, as it is a ve...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Drug Saf
Autores principales: De Berardis, Domenico, Rapini, Gabriella, Olivieri, Luigi, Di Nicola, Domenico, Tomasetti, Carmine, Valchera, Alessandro, Fornaro, Michele, Di Fabio, Fabio, Perna, Giampaolo, Di Nicola, Marco, Serafini, Gianluca, Carano, Alessandro, Pompili, Maurizio, Vellante, Federica, Orsolini, Laura, Martinotti, Giovanni, Di Giannantonio, Massimo
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2018
Materias:
Reviews
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5956953/
https://ncbi.nlm.nih.gov/pubmed/29796248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098618756261
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares